Answers are grounded in this paper and cite their sources.
Review highlights diagnostic inequities and evaluates technologies for decentralized viral disease diagnostics.
Viral diseases continue to impose a major global health burden, yet substantial inequities in access to accurate molecular diagnostics persist, limiting effective surveillance and response. This Review highlights disparities in diagnostic availability, evaluates key molecular diagnostic technologies suited for decentralized settings, and outlines essential factors for translating molecular tests into diverse real-world contexts.
No takes yet. Share an insight, caveat, or question.
Arizti-Sanz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: